Scale -

  • Revenue is 5.04 Rs Cr; Annual Decline is -30 %; Continuous Decline over 3 years
  • Ebitda is 0.38 Rs Cr; Annual Decline is -70 %; 5 Year CAGR is -25 %
  • PBT is 0.2 Rs Cr; Annual Decline is -66 %; in Bottom Quartile
  • PAT is 0.21 Rs Cr; Annual Decline is -64 %; Continuous Decline over 3 years
  • Quarterly Ebitda is 0.19 Rs Cr; in Bottom Quartile

Profitability -

  • PBDIT Margin is 7.39 %; Annual Decline is -58 %; in Bottom Quartile; 5 Year CAGR is -17 %
  • PAT Margin is 4.12 %; Annual Decline is -50 %; Continuous Decline over 3 years
  • Quarterly Ebitda Margin is 18 %; in Bottom Quartile
  • Quarterly Profit margin is 19 %; in Bottom Quartile

Return -

  • ROCE is 0.57 %; Annual Decline is -74 %
  • ROA is 0.41 %; Annual Decline is -64 %; Continuous Decline over 3 years
  • ROE is 0.42 %; Annual Decline is -64 %; Continuous Decline over 3 years
  • Asset Turnover is 10 %; Annual Decline is -29 %; Continuous Decline over 3 years

Efficiency -

  • Current Ratio is 102; in Top Quartile; 5 Year CAGR is 21 %; Annual Decline is -53 %
  • Quick Ratio is 101; in Top Quartile; 5 Year CAGR is 21 %; Annual Decline is -54 %
  • Inventory Turnover Ratio is 12.78; in Top Quartile; Annual Decline is -69 %
  • Operating cash flow is 0.38 Rs Cr; Annual Decline is -87 %; 5 Year CAGR is -39 %

Solvancy -

  • Long term Debt is 0 Rs Cr; Annual Decline is -100 %; Continuous Decline over 3 years; in Top Quartile
  • Total Debt is 0.35 Rs Cr; Annual Decline is -44 %; Continuous Decline over 3 years; in Bottom Quartile
  • Contingent Liabilities is 0.03 Rs Cr; 5 Year CAGR is -64 %; in Top Quartile

Quality -

  • Current Tax/PAT is 14 %; Annual Decline is -62 %
  • Change in Inventories/Total Expenses is -6 %; Annual Decline is -112 %; Continuous Decline over 3 years; in Bottom Quartile
  • Operating cashflow/ebitda is 100 %; in Top Quartile; Annual Decline is -58 %; 5 Year CAGR is -18 %
  • Operating cashflow/PAT is 181 %; in Top Quartile; Annual Decline is -64 %
  • Other Expenses/Total Expenses is 21 %; Continuous Growth over 3 years
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
INSYS Therapeutics, Inc. (NPR.DE) Analyst insights, Price targets and Recommendations
Read More
  • Past/current
NPR Finance Ltd. Estimates – BSE:NPRFIN
Read More
  • Past/current